Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an african isolate: Rhesus macaque model

Journal of Virology

Volumn 75, Issue 23, 2001, Pages 11417-11425

  Ndung'u, T ^a   Lu, Y ^a   Renjifo, B ^a   Touzjian, N ^a   Kushner, N ^a   Pena Cruz, V ^a   Novitsky, V A ^a   Lee, T H ^a   Essex, M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; ENDEMIC DISEASE; EXON; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; INOCULATION; MACACA; MONONUCLEAR CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CHIMERA; DNA PRIMERS; HIV-1; HUMANS; MACACA MULATTA; MALE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD; VIRUS REPLICATION;

EID: 0035168252     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.23.11417-11425.2001     Document Type: Article

References (52)

1. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
2. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
3. CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo
4. R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus
5. Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand
6. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients
7. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev
8. Estimating the rate of occurrence of new HIV infections using serial prevalence surveys: The epidemic in India
9. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India
10. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina)
11. Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian/human immunodeficiency virus infection in pigtailed macaques
12. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
13. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
14. Identification of a major co-receptor for primary isolates of HIV-1
15. Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa
16. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
17. Accelerating the development and future availability of HIV-1 vaccines: Why, when, where, and how?
18. Human immunodeficiency viruses of the developing world
19. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
20. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates
21. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
22. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1
23. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children
24. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs
25. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention
26. Immunophenotypic characterization of simian immunodeficiency virus-infected dendritic cells in cervix, vagina, and draining lymph nodes of rhesus monkeys
27. + T cells and AIDS in pig-tailed macaques
28. Human immunodeficiency virus type I subtypes differ in disease progression
29. + lymphocyte depletion in rhesus monkeys
30. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1
31. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins
32. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
33. Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS
34. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV)
35. Construction and analysis of an infectious human immunodeficiency virus type 1 subtype C molecular clone
36. Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana
37. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya
38. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: A set of 23 full-length clones from botswana
39. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants
40. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys
41. Differences in perinatal transmission between HIV-1 genotypes
42. HIV-1 nomenclature proposal
43. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection
44. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual
45. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells
46. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has altered cytotropism
47. Genetic variability of HIV-1
48. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
49. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression
50. Genotypic and phenotypic characterization of HIV-1 patients with primary infection